Loss of CEACAM1 in hepatocytes causes hepatic fibrosis
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14177 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Sobia Zaidi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA. Hauptthemen laut MEDLINE: Hepatocytes, Insulin Resistance, Liver Cirrhosis, CEACAM1 Protein. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIMHD NIH HHS, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Background
The role of insulin resistance in hepatic fibrosis in Metabolic dysfunction‐Associated SteatoHepatitis (MASH) remains unclear. Carcinoembryonic Antigen‐related Cell Adhesion Molecule1 protein (CEACAM1) promotes insulin clearance to maintain insulin sensitivity and repress de novo lipogenesis, as bolstered by the development of insulin resistance and steatohepatitis in AlbuminCre + Cc1 fl/fl mice with liver‐specific mouse gene encoding CEACAM1 protein (Ceacam1) deletion. We herein investigated whether these mice also developed hepatic fibrosis and whether hepatic CEACAM1 is reduced in patients with MASH at different fibrosis stages.
Methods
AlbuminCre + Cc1 fl/fl mice were fed a regular or a high‐fat diet before their insulin metabolism and action were assessed during IPGTT, and their livers excised for histochemical, immunohistochemical and Western blot analysis. Sirius red staining was used to assess fibrosis, and media transfer was employed to examine whether mutant hepatocytes activated hepatic stellate cells (HSCs). Hepatic CEACAM1 protein levels in patients with varying disease stages were assessed by ELISA.
Results
Hepatocytic deletion of Ceacam1 caused hyperinsulinemia‐driven insulin resistance emanating from reduced hepatic insulin clearance. AlbuminCre + Cc1 fl/fl livers showed inflammation, fibrosis and hepatic injury, with more advanced bridging and chicken‐wire hepatic fibrosis under high‐fat conditions. Media transferred from hepatocytes isolated from mutant mice activated control HSCs, likely owing to their elevated endothelin1 content. Interestingly, hepatic CEACAM1 levels were lower in the livers of patients with MASH and declined gradually with advanced fibrosis stage.
Conclusions
Hepatic CEACAM1 levels declined with progression of MASH in humans. The phenotype of AlbuminCre + Cc1 fl/fl mice assigned a key role to CEACAM1 loss from hepatocytes in hepatic fibrosis independently of other liver cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
- Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, USA.
- Center for Diabetes and Endocrine Research (CeDER), College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio, USA.
- Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
- Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
ORCID-Profile: Sonia M Najjar
Förderung
- NIDDK NIH HHS
- NIMHD NIH HHS
- Foundation for the National Institutes of Health
- NHLBI NIH HHS
Zitieren
APA
Zaidi, S., Asalla, S., Muturi, H. T., Russo, L., Abdolahipour, R., Belew, G. D., Iglesias, M. B., Feraudo, M., Leon, L., Kuo, E., Liu, X., Kumarasamy, S., Ghadieh, H. E., Gatto-Weis, C., Zarrinpar, A., Duarte, S., & Najjar, S. M. (2024). Loss of CEACAM1 in hepatocytes causes hepatic fibrosis. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14177
Vancouver
Zaidi S, Asalla S, Muturi HT, Russo L, Abdolahipour R, Belew GD, et al. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14177
BibTeX
@article{Zaidi2024,
author = {Zaidi, Sobia and Asalla, Suman and Muturi, Harrison T and Russo, Lucia and Abdolahipour, Raziyeh and Belew, Getachew Debas and Iglesias, Maria Benitez and Feraudo, Mary and Leon, Lensay and Kuo, Enoch and Liu, Xiuli and Kumarasamy, Sivarajan and Ghadieh, Hilda E and Gatto-Weis, Cara and Zarrinpar, Ali and Duarte, Sergio and Najjar, Sonia M},
title = {Loss of CEACAM1 in hepatocytes causes hepatic fibrosis},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14177}
}
EUVIMED